Vertex Pharmaceuticals (VRTX) YTD return
Updated November 02, 2026 · Data: Yahoo Finance
Price chart
VRTX vs its sector
Underperforming its sector. VRTX is 7.72 points behind the Health Care sector average, which covers 60 ranked S&P 500 stocks.
Vertex Pharmaceuticals (VRTX) is up +22.01% year-to-date in 2026, ranking #169 of 500 ranked S&P 500 stocks. It closed 2025 at $453.36 and trades at $553.15 as of November 02, 2026. $1,000 invested on December 31, 2025 would be worth $1,220.10 today. That puts it 7.72 points behind the Health Care sector average of +29.73%.
Recent performance
Vertex Pharmaceuticals (VRTX) has gained 9.59% over the past month, outpacing the S&P 500 by 11.94%, and gained 15.55% over the past three months (ahead of the index by 18.07%). It is trading 1.03% below its 52-week high of $558.88, set on 2026-10-30. Momentum is positive: the stock rose in at least 4 of the last 5 sessions.
Latest VRTX news
- Vicapsys Life Sciences Provides Shareholder Update on VICAPSYN(TM) Program Advancing Toward Phase 1 Human Clinical Trial, Vertically Integrated With the Company's Indian Health Service StrategyACCESS Newswire · 2026-11-02
- Jobs Data, More Tech Earnings: What to Watch This WeekThe Wall Street Journal · 2026-11-02
- Stocktwits Pharma Pulse: Biotech Beats The Broader Market — Novo, Pfizer And Moderna Earnings Up NextStocktwits · 2026-11-02
- Vertex Pharmaceuticals earnings: what to look for from VRTXStockStory · 2026-11-01
- Vertex Pharmaceuticals (VRTX) Stock May Still Have Value Following A 190% RunSimply Wall St. · 2026-11-01
Headlines via Yahoo Finance, updated daily.
Where to invest in VRTX
Popular stock brokerages:
We may earn a commission if you sign up through these links, at no extra cost to you.
VRTX YTD return FAQ
What is Vertex Pharmaceuticals (VRTX)'s YTD return in 2026?
Vertex Pharmaceuticals (VRTX) is up +22.01% year-to-date in 2026, as of November 02, 2026.
What was Vertex Pharmaceuticals (VRTX)'s price at the start of 2026?
Vertex Pharmaceuticals (VRTX) closed at $453.36 on December 31, 2025 and trades at $553.15 as of November 02, 2026.
Where does Vertex Pharmaceuticals (VRTX) rank by YTD return in 2026?
Vertex Pharmaceuticals (VRTX) ranks #169 of 500 S&P 500 stocks by YTD return in 2026, as of November 02, 2026.
For informational purposes only, not financial advice.
About · Contact · Privacy Policy · Affiliate Disclosure · Methodology
© 2026 MZX MEDIA LLC. All rights reserved.